third-line therapy

Type: Keyphrase

Name: third-line therapy

First reported May 14 2013 - Updated May 15 2013 - 3 reports

Roche Wins U.S. Approval for Test Targeting Lung Cancer Drug

(Updates with Astellas, Roche shares in sixth paragraph.)May 15 (Bloomberg) -- Roche Holding AG, the world’s biggest maker of cancer drugs, won U.S. approval to sell a gene mutation test that can help doctors pinpoint patients’ likelihood to respond to ... [Published La Repubblica - May 15 2013]

Entities: Roche Holding AG, Lung Cancer, erlotinib, Astellas Pharma Inc, FDA Food & Drug Administration

More Content

sort by: Date \| Relevance
Myriad Genetics Gets a Lift from Angelina Jolie... [Published Equities.com - May 16 2013]
Roche Wins U.S. Approval for Test Targeting Lun... [Published La Repubblica - May 15 2013]
Roche Wins U.S. Approval for Test Targeting Lun... [Published La Repubblica - May 15 2013]
Roche Wins FDA Approval for Test to Target Lung... [Published Bloomberg - May 14 2013]
ArQule Management Discusses Q1 2013 Results - E... [Published Seeking Alpha - May 08 2013]
Avaxia Biologics Nets $6.4M [Published PE Hub News - Dec 19 2012]
Avaxia Biologics Adds $6.4M [Published PE Hub News - Dec 18 2012]